June 18, 2026
A study in mice by the Hospital del Mar Research Institute and the IIBB-CSIC, published in Science Advances, identifies inhibition of the PARP2 protein as a therapeutic target for treating pancreatic cancer, the third leading cause of cancer death worldwide. The study analyses the role of this protein in tumour development and protection, and describes how its elimination leads to tumour cell death and activation of the immune System. Specifically blocking this protein may be a useful strategy for treating a large number of patients with pancreatic cancer and could even be applicable to other types of tumours.
May 19th, 2026
An international study involving researchers from the Hospital del Mar Research Institute reveals a key interaction between two proteins that are fundamental in tumour development. To achieve this, molecular modelling and artificial intelligence techniques were used, revealing for the first time a new structural model that describes a previously unknown cell-signalling mechanism. The research opens the door to designing drugs that act on the interaction between the two proteins, thereby improving current cancer treatments.
Read more sobre "A new pathway for developing cancer drugs discovered"
May 18th, 2026
An international study published in the journal Nature has designated a subset of the so-called dark proteins - proteins with no known function - as peptideins. Characterising them opens the door to studying them and analysing their functions.
Read more sobre "A new study names part of the human genome"
19 de juny de 2026
19 de junio de 2026
16 de juny de 2026
Parc Salut Mar
Passeig Marítim 25-29 Barcelona 08003
See location on Google maps
Phone: 93 248 30 00 · Fax: 93 248 32 54
Information request
© 2006 - 2026 Hospital del Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility
